3 Dividend Stocks Paying Over 6.6% That Are Worth a Closer Look

Annaly Capital yields ~13.2% (dividend $0.70; reported $0.74 EPS last quarter) but carries leverage risk with ~ $105B investment portfolio on $16.1B equity; dividend has been cut in past despite recent coverage. Healthpeak Properties yields ~7.3% with a monthly payout, recently raised $878M via a Janus Living IPO and bought a $600M lab campus to fund outpatient and lab development. Vici Properties yields ~6.6%, has grown its dividend at a 6.6% CAGR since late 2018, and recently acquired hotels/casinos in Canada for $144M and increased its One Beverly Hills loan to $1.5B. These REITs offer high income but differ materially on leverage, asset type, and dividend sustainability.

Analysis

Macro + funding is the real driver here, not headline yield: mortgage REIT economics are dominated by funding/hedge-cost volatility and MBS convexity, while property REITs (healthcare labs, experiential triple-net) are driven by leasing cadence and development stabilization over 6–24 months. That means an identical headline dividend can signal very different risk profiles — stable FFO growth from capital recycling and lease escalators versus levered carry that can swing NAV materially on rate moves and spread widening.

Second-order winners include lab developers, specialized construction firms, and insurance/REIT lenders that provide structured financing — Healthpeak’s capital recycling benefits lab operators and lenders; Vici’s loan-to-own optionality concentrates downside on casino operators but creates acquisition arbitrage for Vici. Conversely, servicers and non-agency credit providers could be hurt if agencies tighten MBS haircuts or prepayment volatility rises, increasing funding costs for mREITs.

Key catalysts and risks: near-term (days–weeks) system shocks are a Fed surprise or an MBS spread blowout that immediately mark-to-market mortgage portfolios; medium term (3–12 months) catalysts are portfolio stabilization of development projects and the pace of leasing/loan-to-own exits; long term (12–36 months) outcomes hinge on secular outpatient/lab demand and consumer leisure spend. The consensus underweights funding convexity and overweights static yield — that gap creates actionable asymmetries across DOC, VICI, and NLY.

Key Decisions for Investors

• Pair trade (3–12 month): Long VICI (size 1.0% NAV) + Long DOC (size 0.8% NAV) funded by Short NLY (size 1.8% NAV) — rationale: capture durable lease escalations and development stabilization while shorting levered mREIT convexity. Target total return 12–20% if spreads stay tight; stop-loss: cut if 10yr moves down >50bps (reduces NLY stress) or if VICI/DOC trade >15% against position.
• Option hedge (6–9 month): Buy NLY 6–9 month puts (ATM, not deep OTM) sized to provide 60–80% coverage of the short exposure to protect vs an MBS/spread widening shock. Expect option cost to be an insurance drag of ~1–2% NAV; payoff is large in a >100bp spread-widening scenario.
• Income overlay for long exposure (3–12 month): After establishing a core long in DOC, sell 6–9 month OTM covered calls (strike ~5–8% OTM) to monetize carry while keeping upside optionality; target incremental yield lift of 150–300bps with capped upside to the strike.
• Tactical short idea (days–months): Initiate a small outright short or buy short-dated puts on NLY into any near-term rally (size 0.5–1.0% NAV) to exploit funding convexity ahead of potential rate/MBS volatility. Risk management: tighten if NLY dividend coverage materially improves or if agency MBS spreads compress >40bps, which would unwind the thesis.